Pregnancy and rheumatic disease: "By the book" or "by the doc"

Clinical Rheumatology

Volumn 28, Issue 1, 2009, Pages 1-9

  Keeling, Stephanie O ^a   Oswald, Anna E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Dermatomyositis; Disease modifying antirheumatic drugs (DMARDs); Polymyositis; Pregnancy; Rheumatic disease; Rheumatoid arthritis; Systemic lupus erythematosus; Systemic sclerosis

Indexed keywords

ABATACEPT; ACETYLSALICYLIC ACID; ADALIMUMAB; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PREDNISONE; RITUXIMAB; SALAZOSULFAPYRIDINE; STEROID;

ANKYLOSING SPONDYLITIS; CONNECTIVE TISSUE DISEASE; DRUG MEGADOSE; FEMALE; HUMAN; LOW DRUG DOSE; MATERNAL CARE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS NEPHRITIS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY, HIGH-RISK; RHEUMATOLOGY; YOUNG ADULT;

EID: 57049177577     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-008-1031-9     Document Type: Review

References (52)

1. Lockshin MD (2006) Treating rheumatic diseases in pregnancy: Dos and don'ts. Ann Rheum Dis 65(Suppl III):iIi58-iii60
2. Ostensen M, Villiger PM (2007) The remission of rheumatoid arthritis during pregnancy. Semin Immunopathol 29:185-191
3. Wegmann TG, Lin H, Guilbert L et al (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon? Immunol Today 14:353-356
4. Ostensen M, Forger F, Villiger P (2006) Cytokines and pregnancy in rheumatic disease. Ann N Y Acad Sci 1069:353-363
5. Chaouat G, Ledee-Bataille N, Dubanchet S et al (2004) Th1/Th2 paradigm in pregnancy: Paradigm lost? Int Arch Allergy Immunol 139:93-119
6. Ashkar AA, Di Santo JP, Croy BA (2000) Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med 192:25970
7. Fukushima K, Miyamoto S, Tsukimori K et al (2005) Tumor necrosis factor and vascular endothelial growth factor induce endothelial integrin repertories, regulating endovascular differentiation and apoptosis in a human extravillous trophoblast cell line. Biol Reprod 73:172-179
8. Kupferminc M, Peaceman A, Aderka D (1995) Soluble tumor necrosis factor receptors in maternal plasma and second-trimester amniotic fluid. Am J Obstet Gynecol 173:900-905
9. Ellis J, Wennerholm UB, Bengtsson A et al (2000) Levels of dimethylarginines and cytokines in mild and severe preeclampsia. Hum Reprod 80:602-608
10. Bahar A, Ghalib H, Moosa R et al (2003) Maternal serum interleukin-6, interleukin-8, tumor necrosis factor-α and interferon-γ in preterm labor. Acta Obstet Gynecol Scand 82:543-549
11. Gerli R, Lunardi C, Vinante F et al (2001) Role of CD30+ T cells in rheumatoid arthritis: A counter-regulatory paradigm for Th1-driven diseases. Trends Immunol 2:72-77
12. Correale J, Arias M, Gilmore W (1998) Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cells clone isolated from multiple sclerosis patients and normal control subjects. J Immunol 161:3365-3374
13. Chrousos G, Torpy D, Gold P (1998) Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med 129:229-240
14. Barrett J, Brennan P, Fiddler M et al (2000) Breastfeeding and postpartum relapse in women with rheumatoid and inflammatory arthritis. Arthritis Rheum 43:1010-1015
15. Somerset D, Zheng Y, Kilby M et al (2004) Normal human pregnancy is associated with an elevation in the immune suppressive CD4+CD25+ regulatory T cell subset. Immunology 112:38-43
16. Brennan P (1997) HLA sharing and history of miscarriage among women with rheumatoid arthritis. Am J Hum Genet 60:738-739
17. Hunt JS (2006) Stranger in a strange land. Immunol Rev 213:36-37
18. Crocker I, Baker P, Fletcher J (2000) Neutrophil function in pregnancy and rheumatoid arthritis. Ann Rheum Dis 59:555-564
19. Ostensen M (2004) New insights into sexual functioning and fertility in rheumatic diseases. Best Pract Res Clin Rheumatol 18(2):219-232
20. Perselin R (1977) The effect of pregnancy on rheumatoid arthritis. Bull Rheum Dis 27:922
21. Silman A, Kay A, Brennan P (1992) Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum 35:152
22. Ostensen M, Husby G, Romberg O (1982) Ankylosing spondylitis and motherhood. Arthritis Rheum 25:140-143
23. Skomsvoll J, Ostensen M, Schei B (2000) Reproduction in women reporting chronic musculoskeletal disorders. Scand J Rheumatol 29:103-107
24. Ostensen M, Ostensen H (1998) Ankylosing spondylitis - the female aspect. J Rheumatol 25:120-124
25. Khamashta M, Hughes G (1996) Pregnancy in systemic lupus erythematosus. Curr Opin Rheumatol 8:424-442
26. Hardy C, Palmer BP, Morton S et al (1999) Pregnancy outcome and family size in systemic lupus erythematosus: A case-control study. Rheumatology 38:559-563
27. Clowse M, Madger L, Witter F et al (2006) Early risk factor for pregnancy loss in lupus. Obstet Gynecol 107:293-299
28. Ruiz-Irastorza G, Lima F, Alves J et al (1996) Increased rate of lupus flare during pregnancy and the puerperium; a prospective study of 78 pregnancies. Br J Rheumatol 35:133
29. Kong N (2006) Pregnancy of a lupus patient - a challenge to the nephrologist. Nephrol Dial Transplant 21:268
30. Lockshin M (1989) Pregnancy does not cause SLE to worsen. Arthritis Rheum 32:665
31. McNeil H, Chesterman C, Krilis S (1991) Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 49:193
32. Gordon P, Khamasthta M, Rosenthal E et al (2004) Anti-52 kDa Ro, anti-60 kDa Ro and anti-La antibody profiles in neonatal lupus. J Rheumatol 31:2480-2487
33. Tsakonas E, Esdaile J, Choquette D et al (1998) A long-term study on hydroxychloroquine withdrawal on exacerbations of systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. Lupus 7(2):80-85
34. Steen V, Conte C, Day N et al (1989) Pregnancy in women with systemic sclerosis. Arthritis Rheum 32:151-157
35. Black C, Stevens W (1989) Scleroderma. Rheum Dis Clin North Am 15:193
36. Scialli A, Buelke-Sam J, Chambers C et al (2004) Communicating risks during pregnancy: A workshop on the use of data from animal developmental toxicity studies in pregnancy labels for drugs. Birth Defects Res A Clin Mol Teratol 70:7-12
37. Park-Wyllie L, Mazzotta P, Pastuszak A et al (2000) Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies. Teratology 62:385-392
38. Blanford A, Murphy B (1977) In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta. Am J Obstet Gynecol 127:264-267
39. Temprano K, Bandlamudi R, Moore T (2005) Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 35:112-121
40. Ostensen M (2001) Rheumatological disorders. Best Pract Res Clin Obstet Gynaecol 15(6):953-969
41. Motta M, Tincani A (2002) Antimalarial agents in pregnancy. Lancet 359:524-525
42. Canadian Rheumatology Association (2000) Canadian Consensus Conference on Hydroxychloroquine. J Rheumatol 27:2919-2920
43. Costedoat-Chalumeau N, Amoura Z, Dunaut P et al (2003) Safety of hydroxychloroquine in pregnant patients with connective tissue disease. Arthritis Rheum 48:3207-3214
44. Chambers C, Tutuncu Z, Johnson D et al (2006) Human pregnancy safety for agents used to treat rheumatoid arthritis: Adequacy of available information and strategies for developing post-marketing data. Arthritis Res Ther 8:215
45. Jarnerot G, Into-Malmberg M (1979) Sulphasalazine treatment during breastfeeding. Scand J Gastroentrol 14:869-871
46. Committee on Drugs (1994) American academy of pediatrics: The transfer of drugs and other chemicals into human milk. Pediatrics 93:137-150
47. Armenti V, Ahlswede K, Ahlswede B et al (1994) National transplantation pregnancy registry-outcome of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 57:502
48. Armenti V, Radomski J, Moritz M et al (2001) Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of pregnancy after transplantation. In: Terasaki P, Cecka JM (eds) Clinical transplants. UCLA Immunogenetics Center, Los Angeles, pp 97-105
49. Katz J, Keenan G, Snith D (2003) Outcome of pregnancy in patients receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Digestive Disease Week May 17-22, 2004 Orlando, FL
50. Ostensen M, Eigenmann G (2004) Etanercept in breast milk. J Rheumatol 31:1017-1018
51. Kimby E, Sverrisdottir A, Elinder G (2004) Safety of rituximab therapy during the first trimester of pregnancy: A case history. Eur J Haematol 72:292-295
52. Herold M, Schnohr S, Bittrich H (2001) Efficacy and safety of a combined rituximab chemotherapy during pregnancy. J Clin Oncol 19:3439